Novolog and Isentress drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Novolog and Isentress. Common interactions include chronic kidney disease among females and pain among males.

The phase IV clinical study analyzes what interactions people who take Novolog and Isentress have. It is created by eHealthMe based on reports of 62 people who take Novolog and Isentress from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 07, 2022

62 people who take Novolog and Isentress together, and have interactions are studied.


What is Novolog?

Novolog has active ingredients of insulin aspart recombinant. It is often used in diabetes. eHealthMe is studying from 51,261 Novolog users for its effectiveness, alternative drugs and more.

What is Isentress?

Isentress has active ingredients of raltegravir potassium. It is often used in hiv infection. eHealthMe is studying from 14,852 Isentress users for its effectiveness, alternative drugs and more.

Number of Novolog and Isentress reports submitted per year:

Novolog and Isentress drug interactions.

Common Novolog and Isentress drug interactions by gender *:

female:

  1. Chronic kidney disease
  2. Fatigue
  3. Pancreatitis
  4. Bone density decreased
  5. Foot fracture
  6. Quality of life decreased
  7. Blister
  8. Chest discomfort
  9. Chest pain
  10. Gait disturbance

male:

  1. Pain
  2. Emotional distress
  3. Renal impairment
  4. Renal transplant
  5. Decreased activity
  6. Depression
  7. Impaired work ability
  8. Metabolic acidosis
  9. Azotaemia
  10. Hyperkalaemia

Common Novolog and Isentress drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anxiety
  2. Bone density decreased
  3. Bone loss
  4. Chronic kidney disease
  5. Depression
  6. Emotional distress
  7. Fracture
  8. Osteonecrosis
  9. Pain
  10. Pneumonia

40-49:

  1. Anhedonia
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Renal failure
  6. Tooth loss
  7. Bone density decreased
  8. Renal impairment
  9. Azotaemia
  10. Hyperkalaemia

50-59:

  1. Ligament sprain
  2. Muscle spasms
  3. Myopia
  4. Neuropathy peripheral
  5. Neutropenia
  6. Osteopenia
  7. Osteoporosis
  8. Proteinuria
  9. Radiculitis brachial
  10. Rib fracture

60+:

  1. Pain
  2. Anhedonia
  3. Atrioventricular dissociation
  4. Back pain
  5. Bradycardia
  6. Chronic kidney disease
  7. Decreased activity
  8. Depression
  9. Dysstasia
  10. Fatigue

Common conditions people have *:

  1. High Blood Pressure: 14 people, 22.58%
  2. High Blood Cholesterol: 10 people, 16.13%
  3. Depression: 9 people, 14.52%
  4. Pain: 8 people, 12.90%
  5. Hyperlipidaemia (presence of excess lipids in the blood): 6 people, 9.68%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 9.68%
  7. Muscle Spasms (muscle contraction): 5 people, 8.06%
  8. Type 2 Diabetes: 4 people, 6.45%
  9. Insomnia (sleeplessness): 4 people, 6.45%
  10. Erection Problems: 4 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Novolog and Isentress?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Novolog and Isentress:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Novolog interactions:

Browse all interactions between Novolog and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Isentress interactions:

Browse all interactions between Isentress and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on insulin aspart recombinant and raltegravir potassium (the active ingredients of Novolog and Isentress, respectively), and Novolog and Isentress (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Novolog and Isentress.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: